Grace Therapeutics
GRCE
24 hedge funds and large institutions have $1.33M invested in Grace Therapeutics in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 11 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0.07% less ownership
Funds ownership: 0.09% → 0.02% (-0.07%)
8% less capital invested
Capital invested by funds: $1.44M → $1.33M (-$117K)
14% less funds holding
Funds holding: 28 → 24 (-4)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$246K |
| 2 |
VF
Virtu Financial
New York
|
+$163K |
| 3 |
Jane Street
New York
|
+$72.7K |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$72.2K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$34.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$625K |
| 2 |
Two Sigma Advisers
New York
|
-$170K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$89K |
| 4 |
OC
Oppenheimer & Co
New York
|
-$73K |
| 5 |
HF
HRT Financial
New York
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Cetera Investment Advisers
Schaumburg,
Illinois
| – | -$5K | -313 | Closed |
|
|
AWM
27
AE Wealth Management
Topeka,
Kansas
| – | -$4K | -274 | Closed |
|
28
Walleye Trading
New York
| – | -$3K | -215 | Closed |
|
|
FWM
29
Frontier Wealth Management
Kansas City,
Missouri
| – | -$3K | -208 | Closed |
|
|
ASN
30
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -42 | Closed |
|
|
SBL
31
Sargent Bickham Lagudis
Boulder,
Colorado
| – | +$35 | +1 | New |
|
|
HFA
32
Hoover Financial Advisors
Malvern,
Pennsylvania
| – | +$347 | +10 | New |
|
GRCE Hedge Fund Activity: Q1 2021 in Review
24 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q1 2021, worth a combined $1.33M — down 8.1% from $1.44M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of GRCE and 7 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Morgan Stanley, adding an estimated $246K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $625K sold.
- 24 institutional investors held Grace Therapeutics (GRCE) as of Q1 2021, down from 28 in Q4 2020.
- Funds reported $1.33M of Grace Therapeutics stock for Q1 2021, down 8.1% quarter-over-quarter.
- 7 funds opened new Grace Therapeutics positions in Q1 2021 and 11 closed out, a net change of -4 holders.
- The largest Grace Therapeutics buyer in Q1 2021 was Morgan Stanley, an estimated $246K added.
- The largest Grace Therapeutics seller in Q1 2021 was Renaissance Technologies, an estimated $625K sold.
Based on aggregated 13F filings for Q1 2021.